Sym013 (Pan-HER) in Patients With Advanced Epithelial Malignancies
NCT02906670
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
32
Enrollment
INDUSTRY
Sponsor class
Stopped
Business reasons
Conditions
Oncology
Interventions
DRUG:
Sym013
Sponsor
Symphogen A/S